China Growth Stocks

[pappy]

Nutrastars revenue & earnings fell short for 2013 with fully diluted eps of $1.30 when I expected $1.40 on less revenue than the company gave guidance for.

International introduction of new products they have been working on pushed back to 2015 & introduction of health drinks is proceeding very slowly making 2014 revenue guidance $47-$50M instead of the $55M+ I was also expecting.

With over $100M in cash I see no need to conserve cash unless a acquisition is planned in the near future.

This effects my near term target of $5.50 as well as my 2014 target of $8.50 while 2015 still looks bright if indeed the developed pills are ready for international introduction then as planned.

I am changing my opinion on Nutrastar to hold unless a acquisition or dividend are forth coming this year.